98 related articles for article (PubMed ID: 16968891)
1. p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury.
Hochegger K; Koppelstaetter C; Tagwerker A; Huber JM; Heininger D; Mayer G; Rosenkranz AR
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F762-8. PubMed ID: 16968891
[TBL] [Abstract][Full Text] [Related]
2. The cyclin-dependent kinase inhibitor p21 is essential for the beneficial effects of renal ischemic preconditioning on renal ischemia/reperfusion injury in mice.
Nishioka S; Nakano D; Kitada K; Sofue T; Ohsaki H; Moriwaki K; Hara T; Ohmori K; Kohno M; Nishiyama A
Kidney Int; 2014 Apr; 85(4):871-9. PubMed ID: 24336034
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of cell cycle regulatory genes after renal ischemia/reperfusion: differential expression of p16(INK4a), p21(WAF1/CIP1) and p27(Kip1) cyclin-dependent kinase inhibitor genes depending on reperfusion time.
Chkhotua AB; Abendroth D; Froeba G; Schelzig H
Transpl Int; 2006 Jan; 19(1):72-7. PubMed ID: 16359379
[TBL] [Abstract][Full Text] [Related]
4. The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury.
Huber JM; Tagwerker A; Heininger D; Mayer G; Rosenkranz AR; Eller K
Am J Physiol Renal Physiol; 2009 Aug; 297(2):F451-60. PubMed ID: 19458122
[TBL] [Abstract][Full Text] [Related]
5. P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor.
Kelly KJ; Plotkin Z; Vulgamott SL; Dagher PC
J Am Soc Nephrol; 2003 Jan; 14(1):128-38. PubMed ID: 12506145
[TBL] [Abstract][Full Text] [Related]
6. Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure.
Megyesi J; Andrade L; Vieira JM; Safirstein RL; Price PM
Kidney Int; 2001 Dec; 60(6):2164-72. PubMed ID: 11737590
[TBL] [Abstract][Full Text] [Related]
7. Morg1 heterozygous mice are protected from acute renal ischemia-reperfusion injury.
Hammerschmidt E; Loeffler I; Wolf G
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1273-87. PubMed ID: 19726548
[TBL] [Abstract][Full Text] [Related]
8. P53-Rb signaling pathway is involved in tubular cell senescence in renal ischemia/reperfusion injury.
Kailong L; Du X; Yani H; Lin Z; Jvrong Y; Ruihua S; Lin C
Biocell; 2007 Aug; 31(2):213-23. PubMed ID: 17902269
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of caspase inhibitors on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidney.
Chatterjee PK; Todorovic Z; Sivarajah A; Mota-Filipe H; Brown PA; Stewart KN; Cuzzocrea S; Thiemermann C
Eur J Pharmacol; 2004 Oct; 503(1-3):173-83. PubMed ID: 15496312
[TBL] [Abstract][Full Text] [Related]
10. Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury.
Zahedi K; Wang Z; Barone S; Prada AE; Kelly CN; Casero RA; Yokota N; Porter CW; Rabb H; Soleimani M
Am J Physiol Renal Physiol; 2003 May; 284(5):F1046-55. PubMed ID: 12554636
[TBL] [Abstract][Full Text] [Related]
11. Pifithrin-alpha attenuates p53-mediated apoptosis and improves cardiac function in response to myocardial ischemia/reperfusion in aged rats.
Liu P; Xu B; Cavalieri TA; Hock CE
Shock; 2006 Dec; 26(6):608-14. PubMed ID: 17117137
[TBL] [Abstract][Full Text] [Related]
12. Endothelin up-regulation and localization following renal ischemia and reperfusion.
Wilhelm SM; Simonson MS; Robinson AV; Stowe NT; Schulak JA
Kidney Int; 1999 Mar; 55(3):1011-8. PubMed ID: 10027938
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of Fenofibrate in renal ischemia reperfusion injury: Involved in suppressing kinase 2 (JAK2)/transcription 3 (STAT3)/p53 signaling activation.
Lv J; Wang X; Liu SY; Liang PF; Feng M; Zhang LL; Xu AP
Pathol Biol (Paris); 2015 Dec; 63(6):236-42. PubMed ID: 26343046
[TBL] [Abstract][Full Text] [Related]
14. Previous ischemia and reperfusion injury results in resistance of the kidney against subsequent ischemia and reperfusion insult in mice; a role for the Akt signal pathway.
Jang HS; Kim J; Kim KY; Kim JI; Cho MH; Park KM
Nephrol Dial Transplant; 2012 Oct; 27(10):3762-70. PubMed ID: 22555250
[TBL] [Abstract][Full Text] [Related]
15. Telomerase deficiency delays renal recovery in mice after ischemia-reperfusion injury by impairing autophagy.
Cheng H; Fan X; Lawson WE; Paueksakon P; Harris RC
Kidney Int; 2015 Jul; 88(1):85-94. PubMed ID: 25760322
[TBL] [Abstract][Full Text] [Related]
16. Renal PKC-ε deficiency attenuates acute kidney injury and ischemic allograft injury via TNF-α-dependent inhibition of apoptosis and inflammation.
Rong S; Hueper K; Kirsch T; Greite R; Klemann C; Mengel M; Meier M; Menne J; Leitges M; Susnik N; Meier M; Haller H; Shushakova N; Gueler F
Am J Physiol Renal Physiol; 2014 Sep; 307(6):F718-26. PubMed ID: 25056349
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and prostaglandin E2.
Hwang HS; Yang KJ; Park KC; Choi HS; Kim SH; Hong SY; Jeon BH; Chang YK; Park CW; Kim SY; Lee SJ; Yang CW
Nephrol Dial Transplant; 2013 May; 28(5):1156-66. PubMed ID: 23229926
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effects of gamma-aminobutyric acid on ischemia/reperfusion-induced renal injury in rats.
Kobuchi S; Shintani T; Sugiura T; Tanaka R; Suzuki R; Tsutsui H; Fujii T; Ohkita M; Ayajiki K; Matsumura Y
Eur J Pharmacol; 2009 Nov; 623(1-3):113-8. PubMed ID: 19765583
[TBL] [Abstract][Full Text] [Related]
19. Effects of p53 inhibitor on survival and death of cells subjected to oxidative stress.
Strosznajder RP; Jesko H; Banasik M; Tanaka S
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():215-21. PubMed ID: 16204796
[TBL] [Abstract][Full Text] [Related]
20. Acute kidney injury induces dramatic p21 upregulation via a novel, glucocorticoid-activated, pathway.
Zager RA; Johnson ACM
Am J Physiol Renal Physiol; 2019 Apr; 316(4):F674-F681. PubMed ID: 30698046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
